Craft

Lonza Biologics Porrino

Revenue

€120.1 M

FY, 2020

Lonza Biologics Porrino Summary

Company Summary

Overview
Lonza Biologics Porriño is a company specializing in late stage clinical and commercial mammalian manufacturing. Its services include raw material release, in-process-control, drug substance and drug product release, and stability testing.
Type
Subsidiary
Status
Active
Founded
2000
HQ
Porriño, ES | view all locations
Sectors

LocationsView all

1 location detected

  • Porriño, GA HQ

    Spain

    Lugar a Relva

Lonza Biologics Porrino Financials

Summary Financials

Revenue (FY, 2020)
€120.1M
Gross profit (FY, 2020)
€49.5M
Net income (FY, 2020)
€9.1M
Cash (FY, 2020)
€591.0K
EBIT (FY, 2020)
€7.8M

Footer menu